Mesa Laboratories, Inc. Plans Quarterly Dividend of $0.16 (NASDAQ:MLAB)

Key Points

• Mesa Laboratories, Inc. has declared a quarterly dividend of $0.16 per share, with the payment scheduled for December 15th to investors of record on November 28th.
• The company has a low dividend payout ratio of 5.2%, indicating its dividend is well-covered by earnings, and expected earnings next year stand at $8.72 per share.
• Shares of Mesa Laboratories have recently seen a price increase, up 2.8% to reach $73.27, with a market capitalization of approximately $402.99 million.

Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) declared a quarterly dividend on Friday, October 3rd, RTT News reports. Investors of record on Friday, November 28th will be given a dividend of 0.16 per share by the medical instruments supplier on Monday, December 15th. This represents a c) dividend on an annualized basis and a dividend yield of 0.9%.

Mesa Laboratories has a dividend payout ratio of 5.2% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Mesa Laboratories to earn $8.72 per share next year, which means the company should continue to be able to cover its $0.64 annual dividend with an expected future payout ratio of 7.3%.

Mesa Laboratories Trading Up 2.8%

Shares of MLAB stock traded up $2.03 during trading hours on Friday, reaching $73.27. 119,839 shares of the stock were exchanged, compared to its average volume of 207,834. Mesa Laboratories has a 12-month low of $55.45 and a 12-month high of $155.12. The company has a current ratio of 0.66, a quick ratio of 0.47 and a debt-to-equity ratio of 0.46. The company's 50-day moving average price is $67.73 and its 200-day moving average price is $92.73. The firm has a market capitalization of $402.99 million, a price-to-earnings ratio of -523.36 and a beta of 0.86.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.